Merger Arbitrage Mondays – July 25, 2011
Merger activity decreased last week with five new deals announced and three closing.
You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours.
Deal Statistics:
New Deals:
- The acquisition of Nalco Holdings (NLC) by Ecolab (ECL) for $5.4 billion in a stock or cash deal. Under the terms of the agreement, Nalco’s shareholders may elect to receive either 0.7005 share of Ecolab common stock or $38.80 in cash, without interest, per share of Nalco common stock. The overall mix of consideration paid to Nalco shareholders will be approximately 30% cash and 70% stock.
- The acquisition of Allos Therapeutics (ALTH) by Amag Pharmaceuticals (AMAG) in an all stock deal for $686 million, where Allos stockholders will receive a fixed ratio of 0.1282 shares of AMAG common stock for each share of Allos common stock they own.
- The acquisition of Icagen (ICGN) by Pfizer (PFE) for $56 million or $6.00 per share in cash.
Only plus or premium subscribers can access this post. Subscribe today.
